Multisite external validation of a risk prediction model for the diagnosis of blood stream infections in febrile pediatric oncology patients without severe neutropenia.

Adam J EsbenshadeZhiguo ZhaoCatherine AftandilianRaya SaabRachel L WattierMelissa BeaucheminTamara P MillerJennifer J WilkesMichael J KellyAlison FernbachMichael JengCindy L SchwartzChristopher C DvorakYu ShyrKarl G M MoonsMaria-Luisa SulisDebra L Friedman

Published in: Cancer (2017)

The results of this external validation demonstrated that the EsVan and EsVan2 models are able to predict BSI across multiple performance sites and, once validated and implemented prospectively, could assist in decision making in clinical practice. Cancer 2017;123:3781-3790. © 2017 American Cancer Society.

Keyphrases

papillary thyroid
clinical practice
squamous cell
end stage renal disease
ejection fraction
newly diagnosed
palliative care
early onset
clinical evaluation